Product How it works Pricing Blog FAQ About Contact
Español English
EspañolEnglish
Log inCreate free account
Balchem

Balchem (NASDAQ: BCPC) insider transactions

In the twelve months to 10 November 2026, executives and directors of Balchem reported 5 open-market sales of 15,200 shares ($2.3m) and 0 open-market purchases, by 3 people, according to the Form 4 filings they submitted to the SEC.

Latest transactions

The 20 most recent transactions in Balchem shares reported on Form 4
DateInsiderRoleTransactionSharesPriceHeld afterFiling
12 February 2026Bengtsson Carl MartinEVP & Chief Financial OfficerShares withheld for tax−302$177.4927,926Form 4
12 February 2026Miyata HatsukiEVP, CLO, & SecretaryShares withheld for tax−181$177.498,745Form 4
12 February 2026Tignor Michael BrentSVP & Chief HR OfficerShares withheld for tax−165$177.4910,723Form 4
12 February 2026Boned FredericSVP/GM, Human Nutri. & HealthShares withheld for tax−203$177.498,978Form 4
12 February 2026Backus William A.VP & Chief Accounting OfficerShares withheld for tax−70$177.496,736Form 4
12 February 2026Harris Theodore LChairman, President & CEOShares withheld for tax−844$177.4991,373Form 4
12 February 2026Reid Martin LutherSVP Chief Supply Chain OfficerShares withheld for tax−116$177.499,073Form 4
12 February 2026van Gunsteren Job LeonardSVP and GM, Specialty ProductsShares withheld for tax−58$177.4910,149Form 4
11 February 2026Fischer David BDirectorGrant or award+870—8,859Form 4
11 February 2026Fish Kathleen BDirectorGrant or award+870—3,429Form 4
11 February 2026Knutson Daniel EDirectorGrant or award+870—6,899Form 4
11 February 2026Rigaud OlivierDirectorGrant or award+870—2,390Form 4
11 February 2026Vicente MonicaDirectorGrant or award+870—2,390Form 4
11 February 2026Wineinger Matthew DavidDirectorGrant or award+870—8,012Form 4
11 February 2026Bengtsson Carl MartinEVP & Chief Financial OfficerGrant or award+3,610—25,926Form 4
11 February 2026Bengtsson Carl MartinEVP & Chief Financial OfficerGrant or award+4,718—30,644Form 4
11 February 2026Bengtsson Carl MartinEVP & Chief Financial OfficerShares withheld for tax−2,416$178.6828,228Form 4
11 February 2026Miyata HatsukiEVP, CLO, & SecretaryGrant or award+1,710—7,556Form 4
11 February 2026Miyata HatsukiEVP, CLO, & SecretaryGrant or award+2,247—9,803Form 4
11 February 2026Miyata HatsukiEVP, CLO, & SecretaryShares withheld for tax−877$178.688,926Form 4

Names appear as in the filing, surname first. A dash in the price column means the filing reports none, as in grants and gifts.

How to read the table

Only open-market purchases and sales are trades the insider chose to make at the market price, and they are the ones counted in the summary above. Grants, option exercises and shares withheld for tax come from pay plans. A sale marked as a 10b5-1 plan was scheduled in advance under a written plan.

Where each row comes from

From the Form 4 that each executive, director or large shareholder must file with the SEC within two business days of a transaction, read up to 10 November 2026. Each row links to its filing on EDGAR. Only transactions in shares are listed, not derivatives, and amended filings are left out. The accounts of the company are on the Balchem page; the method, in data sources.

Information prepared from the Form 4 filings submitted to the SEC, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.